APSR2026-707

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP11-012
P54
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1221140-46904-APSR_2026_Poster_PL_2026_11_21_434821.pdf
Format: PDF Only
09. Asthma
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Chayanis Kositamongkol - Mahidol University Division of Ambulatory Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital Bangkok Thailand
Sukrit Kanchanasurakit - Phrae Hospital Division of Pharmaceutical Care, Department of Pharmacy Phrae Thailand University of Phayao Division of Clinical Pharmacy, Department of Pharmaceutical Care, School of Pharmaceutical Sciences Phayao Thailand University of Phayao Unit of Excellence on Clinical Outcomes Research and IntegratioN (UNICORN), School of Pharmaceutical Sciences Phayao Thailand
Kirati Kengkla - University of Phayao Division of Clinical Pharmacy, Department of Pharmaceutical Care, School of Pharmaceutical Sciences Phayao Thailand University of Phayao Unit of Excellence on Clinical Outcomes Research and IntegratioN (UNICORN), School of Pharmaceutical Sciences Phayao Thailand
Surasak Saokaew - University of Phayao Division of Clinical Pharmacy, Department of Pharmaceutical Care, School of Pharmaceutical Sciences Phayao Thailand University of Phayao Unit of Excellence on Clinical Outcomes Research and IntegratioN (UNICORN), School of Pharmaceutical Sciences Phayao Thailand University of Phayao Division of Social and Administrative Pharmacy, Department of Pharmaceutical Care, School of Pharmaceutical Sciences Phayao Thailand Silpakorn University Faculty of Pharmacy Nakhon Pathom Thailand
Pochamana Phisalprapa - Mahidol University Division of Ambulatory Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital Bangkok Thailand
Patharapan Lersritwimanmaen * Mahidol University Division of Respiratory Disease and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital Bangkok Thailand
 
 
 
 
 
 
 
 
 
Presenting Author Details
Patharapan
Lersritwimanmaen
patharapan.ler@mahidol.ac.th
+66820961113
41-50
Thailand
Original Research
Health-related quality of life in asthma patients receiving GINA step 4–5 treatment according to control status and exacerbation
Maximum 25 words
Abstract Content
GINA step 4–5 represents a key decision point for advanced add-on therapy in patients with asthma. However, data linking asthma control status and exacerbations to health-related quality of life (HRQoL), particularly in resource-limited settings, are limited. We aimed to assess the impact of asthma control status and exacerbations on HRQoL in Thai patients receiving GINA step 4–5 treatment.
We conducted a multicenter cross-sectional study in one secondary and one university hospital in Thailand. Adults aged ≥18 years with asthma receiving treatment at GINA step 4 or 5 were assessed during outpatient follow-up or within 24 hours of an exacerbation requiring an emergency department (ED) visit or hospitalization. Patients with treatment adherence <80% during the previous month or receiving add-on biologics were excluded. In outpatient participants, asthma control status was classified as well-controlled or poorly controlled (partly controlled or uncontrolled) using the GINA assessment tool. HRQoL was assessed using the EQ-5D-5L and the St. George’s Respiratory Questionnaire (SGRQ).
A total of 80 participants were included: 20 well-controlled, 20 poorly controlled, 19 with exacerbation requiring an ED visit, and 21 requiring hospitalization. Mean EQ-5D-5L utility scores (95% CI) were 0.89 (0.80–0.99), 0.86 (0.81–0.91), 0.77 (0.68–0.86), and 0.74 (0.65–0.84), respectively. Compared with the well-controlled group, the other groups had significantly lower utility scores (p<0.05) and higher SGRQ total scores (p<0.05). EQ-5D domains differed from the well-controlled group only during exacerbations: anxiety/depression and usual activities (ED visits); anxiety/depression, usual activities, and pain/discomfort (hospitalization).
In Thai patients with asthma receiving GINA step 4–5 treatment, both poor control and exacerbations significantly impair HRQoL, as measured by generic and respiratory-specific instruments. The impact is most severe during exacerbations requiring hospitalization, affecting a broader range of life domains.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Asthma control, Exacerbation, Health-related quality of life
maximum 3 keywords and no abbreviations, separated by commas
 
306